Skip to content
lifestyle.buyersdesire.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Humacyte, Inc
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
June 10, 2026
Humacyte ATEV Met Superiority Primary Endpoint Compared to Standard of Care AV Fistula in Interim Analysis of V012 Phase 3 Study in Female Dialysis Access Patients
June 10, 2026
Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access
May 26, 2026
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
May 20, 2026
Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer
May 12, 2026
Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026
May 8, 2026
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026
April 27, 2026
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
April 24, 2026
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
April 22, 2026
1
2
Next Page
→